Zdrowie i gospodarka · 06/12/2024
FDA Announces Draft Guidance for Expedited Program for Serious Conditions-Accelerated Approval of Drugs and Biologics
The FDA is releasing a draft guidance for industry on its Expedited Program for Serious Conditions, which aims to speed up the development and review of life-threatening drugs and biologics.